
JCO Precision Oncology
@jcopo_asco
Original research, reports, opinions, and reviews advancing the science and practice of #precisiononcology. Part of @JCO_ASCO family of journals.
ID: 748873646303748100
http://ascopubs.org/journal/po 01-07-2016 13:39:25
1,1K Tweet
5,5K Followers
207 Following







Quantifying the Value of Molecular Tumor Board: Discordance Rec Rate & Drug Cost Avoidance [Oct 20, 2022] @mkwalters305 et al. JCO Precision Oncology ascopubs.org/doi/abs/10.120β¦ #PrecisionMedicine #hpeonc Table 2
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo Quantifying the Value of Molecular Tumor Board: Discordance Rec Rate & Drug Cost Avoidance [Oct 20, 2022] @mkwalters305 et al. <a href="/JCOPO_ASCO/">JCO Precision Oncology</a> ascopubs.org/doi/abs/10.120β¦ #PrecisionMedicine #hpeonc Table 2 Quantifying the Value of Molecular Tumor Board: Discordance Rec Rate & Drug Cost Avoidance [Oct 20, 2022] @mkwalters305 et al. <a href="/JCOPO_ASCO/">JCO Precision Oncology</a> ascopubs.org/doi/abs/10.120β¦ #PrecisionMedicine #hpeonc Table 2](https://pbs.twimg.com/media/GqsOdyXXUAAtugp.jpg)





JCO Precision Oncology #egfr #radiation #osimertinib #oligoprogression #LCSM βοΈ The paper is here. ascopubs.org/doi/abs/10.120β¦



"Ultimately, we need to implement #universal #somatic and #germlinetesting in all #patients with #cancer if we are serious about beating most cancer types. " Vivek Subbiah, MD et al. Nature Medicine c/w ascopubs.org/doi/10.1200/PO⦠JCO Precision Oncology ASCO Invitae Labcorp




Blood MicroRNAs as Biomarkers of Immunotherapy in #lungcancer. Co-authored by Claudia Proto arsela prelaj Marina Garassino Read the full article: brnw.ch/21wSXzC #lcsm

Sequential Antibody-Drug Conjugate Therapy in Patients With Metastatic Breast Cancer Treated With Sacituzumab Govitecan and Trastuzumab Deruxtecan JCO Precision Oncology ascopubs.org/doi/10.1200/POβ¦